Skip to content

Homoeopathic treatment of chronic low back pain.

Management of chronic low back pain with individualized homoeopathic medicine in adult population with special emphasis on accessory circumstances: an open label single arm pre and post clinical study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098226
Enrollment
66
Registered
2025-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Intervention1: Individualized Homoeopathic Medicine: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will consist of 1 cane sugar glob
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

Dr Arnab Ranjan Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from chronic low back pain (ICD -11 code MG30.02) 2. Participants fulfilling AAPT Diagnostic criteria for Chronic Musculoskeletal Low Back Pain Dimension 1 3. Age between 18 to 60 years 4. Patients with radiological diagnosis indicating different cases of low back pain with mild to moderate degenerative radiological changes. 5. Patient of either sex. 6. Patients, who can read or write or understand English, Bengali, Hindi. 7. Patient given written consent to participate.

Exclusion criteria

Exclusion criteria: 1. Patient not willing to participate in study. 2. Patient too sick for consultation. 3. Patients with severe degenerative changes in radiological findings like spinal abnormalities, malignancy, fracture, cauda equina syndrome, infection, ankylosing spondylitis, epidural abscess, congenital abnormalities, etc. 4. Patient with history of spinal surgery or requiring or willing for the same. 5. Patient undergoing Homoeopathic treatment for chronic disease within last 6 weeks. 6. Non-ambulant patient. 7. Obese patient (BMI 30.0 or more) 8. Patient with uncontrolled diabetes, hypertension, cancer, any other systemic illness or vital organ failure. 9. Vulnerable population- unconscious, differently abled, terminally ill, or critically ill patients, institutionalized subjects, mentally incompetent, patients with psychiatric illness. 10. Patients with immunocompromised state. 11. Pregnant and puerperal woman, lactating mother. 12. Patients with habits of tobacco chewing, and or smoking, alcoholism, and or any other forms of substance abuse and or dependence. 13. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
1.To measure the changes in Oswestry Disability Index (ODI) questionnaire after 3 months of intervention.Timepoint: At Baseline and 3rd month

Secondary

MeasureTime frame
1.To measure the changes in the pain intensity in Numerical Pain Rating Scale 2.To measure the changes in EQ-5D-5L Questionnaire 3. To assess the role of accessory circumstances. 4. To ascertain and shortlist the most frequently indicated homoeopathic medicines in the treatment of chronic low back pain Timepoint: Baseline, every month upto 3months Baseline, every month upto 3months At 3rd month At 3rd month

Countries

India

Contacts

Public ContactProf Dr Aloke Kumar Ghosh

The Calcutta Homoeopathic Medical College and Hospital

dralok1974ghosh@gmail.com9836584268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026